News

EscharEx ® is a bromelain-based, bioactive enzymatic therapy in advanced clinical development for the debridement of chronic and hard-to-heal wounds. Designed for topical, once-daily application, ...
"Our study is a first step in dramatically expanding our repertoire of effective and safe CRISPR-Cas9 enzymes. In our manuscript, we demonstrate the utility of these PAMmla-predicted enzymes to ...
The global wound debridement products market is poised for moderate yet consistent growth over the next decade. From an estimated market size of USD 5.0 billion in 2025, it is expected to reach USD ...
When it comes to absorption, digestive enzymes are crucial. “The best digestive enzymes, whether natural or in supplemental form, help ensure your food is properly broken down so your body can ...